Jordi Caballé-Serrano

Jordi Caballé-Serrano

Auto-generated profile, based on publicly available information

Jordi Caballé-Serrano

Department of Oral and Maxillofacial Surgery Faculty of Dentistry, International University of Catalonia Barcelona Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2016 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
JCJordi Caballé‐Serrano
Jordi Caballé‐Serrano
KSKosaku Sawada
Kosaku Sawada
RMRichard J. Miron
Richard J. Miron
DBDieter D. Bosshardt
Dieter D. Bosshardt
DBDaniel Buser
Daniel Buser
RGReinhard Gruber
Reinhard Gruber

1 January 2019 in Journal of Periodontal & Implant Science
Verified
Journal Article
Open access
DKDae-Young Kang
Dae-Young Kang
MKMyeongjin Kim
Myeongjin Kim
SLSung-Jo Lee
Sung-Jo Lee
ICIn-Woo Cho
In-Woo Cho
HSHyun-Seung Shin
Hyun-Seung Shin
JPJung-Chul Park
Jung-Chul Park
The aim of this retrospective study was to determine the prevalence of early implant failure using a single implant system and to identify the factors contributing to early implant failure. Patients who received implant treatment with a single implant system (Luna®, Shinhung, Seoul, Korea) at Dankook University Dental Hospital from 2015 to 2017 were enrolled. The following data were collected for analysis: sex and age of the patient, seniority of the surgeon, diameter and length of the implant, position in the dental arch, access approach for sinus-floor elevation, and type of guided bone regeneration (GBR) procedure. The effect of each predictor was evaluated using the crude hazard ratio and the adjusted hazard ratio (aHR) in univariate and multivariate Cox regression analyses, respectively. This study analyzed 1,031 implants in 409 patients, who comprised 169 females and 240 males with a median age of 54 years (interquartile range [IQR], 47-61 years) and were followed up for a median of 7.2 months (IQR, 5.6-9.9 months) after implant placement. Thirty-five implants were removed prior to final prosthesis delivery, and the cumulative survival rate in the early phase at the implant level was 95.6%. Multivariate regression analysis revealed that seniority of the surgeon (residents: aHR=2.86; 95% confidence interval [CI], 1.37-5.94) and the jaw in which the implant was placed (mandible: aHR=2.31; 95% CI, 1.12-4.76) exerted statistically significant effects on early implant failure after adjusting for sex, age, dimensions of the implant, and type of GBR procedure (preoperative and/or simultaneous) (P<0.05). Prospective studies are warranted to further elucidate the factors contributing to early implant failure. In the meantime, surgeons should receive appropriate training and carefully select the bone bed in order to minimize the risk of early implant failure.

1 April 2012 in Bone
Verified
Journal Article
Closed access
MAM. Atari
M. Atari
JCJ. Caballé-Serrano
J. Caballé-Serrano
CGC. Gil-Recio
C. Gil-Recio
CGC. Giner-Delgado
C. Giner-Delgado
EME. Martínez-Sarrà
E. Martínez-Sarrà
LGLuís Giner-Tarrida
Luís Giner-Tarrida

19 September 2014 in The International Journal of Oral and Maxillofacial Implants
Verified
Journal Article
Closed access
JCJordi Caballe-Serrano
Jordi Caballe-Serrano
DBDieter Bosshardt
Dieter Bosshardt
DBDaniel Buser
Daniel Buser
RGReinhard Gruber
Reinhard Gruber
Jordi Caball?-Serrano, DDS, MSc/Dieter D. Bosshardt, PhD/Daniel Buser, DDS/Reinhard Gruber, PhD: Purpose: Autografts are considered to support bone regeneration. Paracrine factors released from cortical bone might contribute to the overall process of graft consolidation. The aim of this study was to characterize the paracrine factors by means of proteomic analysis. Materials and Methods: Bone-conditioned medium (BCM) was prepared from fresh bone chips of porcine mandibles and subjected to proteomic analysis. Proteins were categorized and clustered using the bioinformatic tools UNIPROT and PANTHER, respectively. Results: Proteomic analysis showed that BCM contains more than 150 proteins, of which 43 were categorized into ?secreted? and ?extracellular matrix.? Growth factors that are not only detectable in BCM, but potentially also target cellular processes involved in bone regeneration, eg, pleiotrophin, galectin-1, transforming growth factor beta (TGF-β)-induced gene (TGFBI), lactotransferrin, insulin-like growth factor (IGF)?binding protein 5, latency-associated peptide forming a complex with TGF-β1, and TGF-β2, were discovered. Conclusion: The present results demonstrate that cortical bone chips release a large spectrum of proteins with the possibility of modulating cellular aspects of bone regeneration. The data provide the basis for future studies to understand how these paracrine factors may contribute to the complex process of graft consolidation.

1 July 2015 in The International Journal of Oral and Maxillofacial Implants
Verified
Journal Article
Closed access
MZMatthias Zimmermann
Matthias Zimmermann
JCJordi Caballé-Serrano
Jordi Caballé-Serrano
DBDieter Bosshardt
Dieter Bosshardt
hendrik jan ankersmithendrik jan ankersmit
hendrik jan ankersmit
DBDaniel Buser
Daniel Buser
RGReinhard Gruber
Reinhard Gruber
Matthias Zimmermann, DMD/Jordi Caball?-Serrano, DDS/Dieter D. Bosshardt, PhD/Hendrik J. Ankersmit, MD/Daniel Buser, DDS/Reinhard Gruber, PhD: Purpose: Autologous bone is used for augmentation in the course of oral implant placement. Bone grafts release paracrine signals that can modulate mesenchymal cell differentiation in vitro. The detailed genetic response of the bone-derived fibroblasts to these paracrine signals has remained elusive. Paracrine signals accumulate in bone-conditioned medium (BCM) prepared from porcine cortical bone chips. Materials and Methods: In this study, bone-derived fibroblasts were exposed to BCM followed by a whole genome expression profiling and downstream quantitative reverse transciptase polymerase chain reaction of the most strongly regulated genes. Results: The data show that ADM, IL11, IL33, NOX4, PRG4, and PTX3 were differentially expressed in response to BCM in bone-derived fibroblasts. The transforming growth factor beta (TGF-β) receptor 1 antagonist SB431542 blocked the effect of BCM on the expression of the gene panel, except for IL33. Conclusion: These in vitro results extend existing evidence that cortical bone chips release paracrine signals that provoke a robust genetic response in mesenchymal cells that is not exclusively mediated via the TGF-β receptor. The present data provide further insights into the process of graft consolidation.

24 May 2019 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
JCJordi Caballé‐Serrano
Jordi Caballé‐Serrano
VCVivianne Chappuis
Vivianne Chappuis
AMAlberto Monje
Alberto Monje
DBDaniel Buser
Daniel Buser
DBDieter D. Bosshardt
Dieter D. Bosshardt